Literature DB >> 26808227

On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets.

Georges Vauquelin1, Isabelle Van Liefde1, David C Swinney2.   

Abstract

'Induced-fit' binding of drugs to a target may lead to high affinity, selectivity and a long residence time, and this mechanism has been proposed to apply to many drugs with high clinical efficacy. It is a multistep process that initially involves the binding of a drug to its target to form a loose RL complex and a subsequent isomerization/conformational change to yield a tighter binding R'L state. Equations with the same mathematical form may also describe the binding of bivalent antibodies and related synthetic drugs. Based on a selected range of 'microscopic' rate constants and variables such as the ligand concentration and incubation time, we have simulated the experimental manifestations that may go along with induced-fit binding. Overall, they validate different experimental procedures that have been used over the years to identify such binding mechanisms. However, they also reveal that each of these manifestations only becomes perceptible at particular combinations of rate constants. The simulations also show that the durable nature of R'L and the propensity of R'L to be formed repeatedly before the ligand dissociates will increase the residence time. This review may help pharmacologists and medicinal chemists obtain preliminary indications for identifying an induced-fit mechanism.
© 2016 The British Pharmacological Society.

Mesh:

Substances:

Year:  2016        PMID: 26808227      PMCID: PMC4940813          DOI: 10.1111/bph.13445

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  103 in total

Review 1.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology.

Authors:  Richard R Neubig; Michael Spedding; Terry Kenakin; Arthur Christopoulos
Journal:  Pharmacol Rev       Date:  2003-12       Impact factor: 25.468

Review 2.  On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets.

Authors:  Georges Vauquelin; Isabelle Van Liefde; David C Swinney
Journal:  Br J Pharmacol       Date:  2016-03-15       Impact factor: 8.739

Review 3.  Drug-target residence time and its implications for lead optimization.

Authors:  Robert A Copeland; David L Pompliano; Thomas D Meek
Journal:  Nat Rev Drug Discov       Date:  2006-08-04       Impact factor: 84.694

Review 4.  Target-drug interactions: first principles and their application to drug discovery.

Authors:  Sara Núñez; Jennifer Venhorst; Chris G Kruse
Journal:  Drug Discov Today       Date:  2011-07-12       Impact factor: 7.851

5.  New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection.

Authors:  Javier Garcia-Perez; Patricia Rueda; Isabelle Staropoli; Esther Kellenberger; Jose Alcami; Fernando Arenzana-Seisdedos; Bernard Lagane
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

6.  Determining the potency and molecular mechanism of action of insurmountable antagonists.

Authors:  Terry Kenakin; Stephen Jenkinson; Christian Watson
Journal:  J Pharmacol Exp Ther       Date:  2006-07-20       Impact factor: 4.030

7.  Binding of the antagonist [3H]candesartan to angiotensin II AT1 receptor-transfected [correction of tranfected] Chinese hamster ovary cells.

Authors:  F Fierens; P M Vanderheyden; J P De Backer; G Vauquelin
Journal:  Eur J Pharmacol       Date:  1999-02-19       Impact factor: 4.432

Review 8.  Sartan-AT1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism.

Authors:  I Van Liefde; G Vauquelin
Journal:  Mol Cell Endocrinol       Date:  2008-06-21       Impact factor: 4.102

9.  Effect of saponin and filipin on antagonist binding to AT 1 receptors in intact cells.

Authors:  Ilse Verheijen; Dieter Tourlousse; Patrick M L Vanderheyden; Jean-Paul De Backer; Georges Vauquelin
Journal:  Biochem Pharmacol       Date:  2004-04-15       Impact factor: 5.858

Review 10.  Design strategies to address kinetics of drug binding and residence time.

Authors:  Kevin P Cusack; Ying Wang; Michael Z Hoemann; Jasmina Marjanovic; Roland G Heym; Anil Vasudevan
Journal:  Bioorg Med Chem Lett       Date:  2015-03-05       Impact factor: 2.823

View more
  8 in total

Review 1.  On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets.

Authors:  Georges Vauquelin; Isabelle Van Liefde; David C Swinney
Journal:  Br J Pharmacol       Date:  2016-03-15       Impact factor: 8.739

Review 2.  Link between a high k on for drug binding and a fast clinical action: to be or not to be?

Authors:  Georges Vauquelin
Journal:  Medchemcomm       Date:  2018-08-16       Impact factor: 3.597

3.  Effects of target binding kinetics on in vivo drug efficacy: koff , kon and rebinding.

Authors:  Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

4.  Distinct in vivo target occupancy by bivalent- and induced-fit-like binding drugs.

Authors:  Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2017-10-18       Impact factor: 8.739

5.  Drug-Target Kinetics in Drug Discovery.

Authors:  Peter J Tonge
Journal:  ACS Chem Neurosci       Date:  2017-07-14       Impact factor: 4.418

6.  Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptor.

Authors:  Reggie Bosma; Leigh A Stoddart; Victoria Georgi; Monica Bouzo-Lorenzo; Nick Bushby; Loretta Inkoom; Michael J Waring; Stephen J Briddon; Henry F Vischer; Robert J Sheppard; Amaury Fernández-Montalván; Stephen J Hill; Rob Leurs
Journal:  Sci Rep       Date:  2019-05-27       Impact factor: 4.379

7.  A two-state model for the kinetics of competitive radioligand binding.

Authors:  Dong Guo; Lambertus A Peletier; Lloyd Bridge; Wesley Keur; Henk de Vries; Annelien Zweemer; Laura H Heitman; Adriaan P IJzerman
Journal:  Br J Pharmacol       Date:  2018-04-17       Impact factor: 8.739

8.  Ligand with Two Modes of Interaction with the Dopamine D2 Receptor-An Induced-Fit Mechanism of Insurmountable Antagonism.

Authors:  Richard Ågren; Hugo Zeberg; Tomasz Maciej Stępniewski; R Benjamin Free; Sean W Reilly; Robert R Luedtke; Peter Århem; Francisco Ciruela; David R Sibley; Robert H Mach; Jana Selent; Johanna Nilsson; Kristoffer Sahlholm
Journal:  ACS Chem Neurosci       Date:  2020-09-15       Impact factor: 4.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.